Tumor necrosis factor alpha in children with sickle cell disease in stable condition

Journal of the National Medical Association

Volumn 89, Issue 9, 1997, Pages 609-615

  Kuvibidila, Solo ^a   Gardner, Renée ^a   Ode, David ^a   Yu, Lolie ^a   Lane, Gerald ^a   Warrier, Raj P ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anthropometry; Infection; Pain crisis; Sickle cell disease; Tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ARTICLE; BLOOD; CHILD; ENZYME IMMUNOASSAY; GROWTH DISORDER; HUMAN; INFANT; PRESCHOOL CHILD; SICKLE CELL TRAIT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; GROWTH DISORDERS; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; SICKLE CELL TRAIT; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031230129     PISSN: 00279684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Lembo NJ. Pneumococcal infections in children with sickle cell disease: increased incidence, immunological defects, vaccine failure, and prospects for the future. J Natl Med Assoc. 1981;73:43-45.
2. De Ceulaer K, Pagliuca A, Forbes M, Maude GH, Serjeant BE, Serjeant GR. Recurrent infections in sickle cell disease: hematological and immune studies. Clin Chim Acta. 1985;148:161-165.
3. John AB, Ramlal A, Jackson H, Maude GH, Sharma WA, Serjeant GR. Prevention of pneumococcal infection in children with homozygous sickle cell disease. BMJ. 1984;288:1567-1570.
4. Barrett D, Ammann AJ. Pneumococcal vaccine in sickle cell disease: IgG and IgM antibody response. Reviews of Infectious Diseases. 1981;3:S179-S182.
5. Chudwin DS, Korenblit AD, Kingzette M, Artrip S, Rao S. Increased activation of the alternative complement pathway in sickle cell disease. Clin Immunol Immunopathol. 1985;37:93-97.
6. Buchanan GR, Smith SJ. Pneumococcal septicemia despite pneumococcal vaccine and prescription of penicillin prophylaxis in children with sickle cell anemia. Am J Dis Child. 1986;140:428-432.
7. Maury CP. Monitoring the acute phase response: comparison of tumor necrosis factor (cachectin) and C-reactive protein responses in inflammatory and infectious diseases. J Clin Pathol. 1989;43:1078-1082.
8. Tracey KJ, Lowry SF, Cerami A. Cachectin: a hormone that triggers acute shock and chronic cachexia. J Infect Dis. 1988;157:413-420.
9. Nelson A, Bagby GJ, Bainton B, Wilson LA, Thompson JJ, Summer WR. Compartmentalization of intra-alveolar and systemic lipopolysaccharide-induced tumor necrosis factor-α and pulmonary inflammatory response. J Infect Dis. 1989;159:189-194.
10. Waage A, Halstense A, Espevik T. Association between tumour necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet. 1987;1:355-357.
11. Gamble JR, Halan JM, Klebanoff SJ, Vadas MA. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci USA. 1985;82:8667-8671.
12. Hebbel R, Yamada O, Moldow CF, Jacob HS, White JG, Eaton JW. Abnormal adherence of sickle erythrocytes to cultured vascular endothelium. Possible mechanisms for microvascular occlusion in sickle cell disease. J Clin Invest. 1980;65:154-160.
13. Hebbel RP, Boogarts MAR, Eaton JW, Steinberg MH. Erythrocyte adherence to endothelium in sickle cell anemia. A possible determinant of disease severity. N Engl J Med. 1980;302:992-995.
14. Francis RB, Haywood J. Elevated immunoreactive tumor necrosis factor and interleukin-1 in sickle cell disease. J Natl Med Assoc. 1992;84:611-615.
15. Malave I, Persomo Y, Escalona E, Rodriguez E, Anchustegui M, Malave M, et al. Levels of tumor necrosis factor alpha/cachectin (TNF-α) in sera from patients with sickle cell disease. Acta Haematol. 1993,90:172-176.
16. Lowry MF, Desai P, Ashcroft MT, Serjeant BE, Serjeant GR. Heights and weights of Jamaican children with homozygous sickle cell disease. Hum Biol. 1977;49:429-436.
17. Gray NT, Bartlet JM, Kolosa KM, Marcurid SP, Holbrook CT, Horner RD. Nutritional status and dietary intake of children with sickle cell anemia. American Journal of Pediatrric Hematology/Oncology. 1992;14:57-61.
18. Warrier RP, Kuvibidila S, Gordon L, Humbert J. Transport proteins and acute phase proteins in children with sickle cell anemia. J Natl Med Assoc. 1994;86:33-39.
19. Munro HB. Differences among group means: one way analysis of variance. In: Munro HB, Page EB, eds. Statistical Methods for Health Care Research. Philadelphia, Pa: JB Lippincott Co; 1993:109-125.
20. Maury CPJ. Tumour necrosis factor - an overview. Acta Medico Scandinavica. 1986;220:387-394.
21. Scuderi P, Sterling KE, Lam K, Finley PR, Ryan KJ, Ray CG, et al. Raised serum levels of tumour necrosis factor in parasitic infections. Lancet. 1986;2:1364-1365.
22. Silva CL, Faccioli LH, Rocha GM. The role of cachectin/TNF in the pathogenesis of tuberculosis. Brazilian Journal of Medical and Biological Research. 1988;21:489-492.
23. Saarinen UM, Koskelo EK, Teppo AM, Siimes MA. Tumor necrosis factor in children with malignancies. Cancer Res. 1990;50:592-595.